Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome

Fertility and Sterility

Volumn 99, Issue 7, 2013, Pages

  Butler, Miriam S ^a   Yang, Xing ^c   Ricciardelli, Carmela ^b   Liang, Xiaoyan ^c   Norman, Robert J ^b   Tilley, Wayne D ^a   Hickey, Theresa E ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ovary; PCOS; SGTA

Indexed keywords

ANDROGEN RECEPTOR; CHAPERONE; GLUTAMINE; MESSENGER RNA; SMALL GLUTAMINE RICH TETRATRICOPEPTIDE REPEAT CONTAINING PROTEIN ALPHA; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORE BIOPSY NEEDLE; CYTOPLASM; FEMALE; FEMALE INFERTILITY; GENE EXPRESSION; GENE SILENCING; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFERTILITY THERAPY; MALE; NUCLEAR LOCALIZATION SIGNAL; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PRIMORDIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TETRATRICOPEPTIDE REPEAT; THECA CELL; TUMOR CELL;

EID: 84878472879     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.01.140     Document Type: Article

References (31)

1. R.J. Norman, D. Dewailly, R.S. Legro, and T.E. Hickey Polycystic ovary syndrome Lancet 370 2007 685 697
2. W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, and M.J. Davies The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod 25 2010 544 551
3. D. Ehrmann, R. Barnes, and R. Rosenfield Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion Endocr Rev 16 1995 322 353
4. H.F. Escobar-Morreale, M. Luque-Ramirez, and J.L. San Millan The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome Endocr Rev 26 2005 251 282
5. P. Amato, and J.L. Simpson The genetics of polycystic ovary syndrome Best Pract Res Clin Obstet Gynaecol 18 2004 707 718
6. M.O. Goodarzi, N. Xu, J. Cui, X. Guo, Y.I. Chen, and R. Azziz Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome Hum Reprod 23 2008 1214 1219
7. M. Urbanek, A. Woodroffe, K.G. Ewens, E. Diamanti-Kandarakis, R.S. Legro, and J.F. Strauss III Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2 J Clin Endocrinol Metab 90 2005 6623 6629
8. M. Urbanek The genetics of the polycystic ovary syndrome Nat Clin Pract Endocrinol Metab 3 2007 103 111
9. D.R. Stewart, B.A. Dombroski, M. Urbanek, W. Ankener, K.G. Ewens, and J.R. Wood Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity J Clin Endocrinol Metab 91 2006 4112 4117
10. S. Tucci, W. Futterweit, E.S. Concepcion, D.A. Greenberg, R. Villanueva, and T.F. Davies Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus J Clin Endocrinol Metab 86 2001 446 449
11. M. Urbanek, R.S. Legro, D.A. Driscoll, R. Azziz, D.A. Ehrmann, and R.J. Norman Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc Natl Acad Sci U S A 96 1999 8573 8578
12. K.G. Ewens, D.R. Stewart, W. Ankener, M. Urbanek, J.M. McAllister, and C. Chen Family-based analysis of candidate genes for polycystic ovary syndrome J Clin Endocrinol Metab 95 2010 2306 2315
13. G. Buchanan, C. Ricciardelli, J.M. Harris, J. Prescott, Z.C.-L. Yu, and L. Jia Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein α Cancer Res 67 2007 10087 10096
14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
15. R. Ivell, M. Balvers, R. Domagalski, H. Ungefroren, N. Hunt, and W. Schulze Relaxin-like factor: a highly specific and constitutive new marker for Leydig cells in the human testis Mol Hum Reprod 3 1997 459 466
16. W.D. Tilley, S.S. Lim-Tio, D.J. Horsfall, J.O. Aspinall, V.R. Marshall, and J.M. Skinner Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis Cancer Res 54 1994 4096 4102
17. R.L. Robker, L.K. Akison, B.D. Bennett, P.N. Thrupp, L.R. Chura, and D.L. Russell Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women J Clin Endocrinol Metab 94 2009 1533 1540
18. S. Chadha, T.D. Pache, J.M. Huikeshoven, A.O. Brinkmann, and T.H. van der Kwast Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women Hum Pathol 25 1994 1198 1204
19. K. Horie, K. Takakura, H. Fujiwara, H. Suginami, S. Liao, and T. Mori Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression Hum Reprod 7 1992 184 190
20. T. Suzuki, H. Sasano, N. Kimura, M. Tamura, T. Fukaya, and A. Yajima Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes Hum Reprod 9 1994 1589 1595
21. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline J Clin Endocrinol Metab 91 2006 4237 4245
22. E. Jansen, J.S.E. Laven, H.B.R. Dommerholt, J. Polman, C. van Rijt, and C. van den Hurk Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients Mol Endocrinol 18 2004 3050 3063
23. A. Sen, and S.R. Hammes Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function Mol Endocrinol 24 2010 1393 1403
24. C.M. Coenen, C.M. Thomas, G.F. Borm, J.M. Hollanders, and R. Rolland Changes in androgens during treatment with four low-dose contraceptives Contraception 53 1996 171 176
25. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone J Natl Cancer Inst 90 1998 1774 1786
26. J.M. Schildkraut, P.J. Schwingl, E. Bastos, A. Evanoff, and C. Hughes Epithelial ovarian cancer risk among women with polycystic ovary syndrome Obstet Gynecol 88 1996 554 559
27. P.H. Wang, and C. Chang Androgens and ovarian cancers Eur J Gynaecol Oncol 25 2004 157 163
28. J.A. Schantl, M. Roza, A.P. De Jong, and G.J. Strous Small glutamine-rich tetratricopeptide repeat-containing protein (SGT) interacts with the ubiquitin-dependent endocytosis (UbE) motif of the growth hormone receptor Biochem J 373 2003 855 863
29. H. Wang, H. Shen, Y. Wang, Z. Li, H. Yin, and H. Zong Overexpression of small glutamine-rich TPR-containing protein promotes apoptosis in 7,721 cells FEBS Lett 579 2005 1279 1284
30. M. Winnefeld, A. Grewenig, M. Schnolzer, H. Spring, T.A. Knoch, and E.C. Gan Human SGT interacts with Bag-6/Bat-3/Scythe and cells with reduced levels of either protein display persistence of few misaligned chromosomes and mitotic arrest Exp Cell Res 312 2006 2500 2514
31. H. Yin, H. Wang, H. Zong, X. Chen, Y. Wang, and X. Yun SGT, a Hsp90beta binding partner, is accumulated in the nucleus during cell apoptosis Biochem Biophys Res Commun 343 2006 1153 1158